Patents by Inventor Yanfeng Li

Yanfeng Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11618778
    Abstract: Provided are a chimeric antigen receptor targeting CD20 antigen and a preparation method thereof. The extracellular antigen binding domain of the chimeric antigen receptor includes an antibody heavy chain variable region shown in SEQ ID NO: 7 or 9 or 33 and an antibody light chain variable region shown in SEQ ID NO: 11 or 13 or 35, and is capable of killing tumor cells.
    Type: Grant
    Filed: April 19, 2022
    Date of Patent: April 4, 2023
    Assignee: CELLULAR BIOMEDICINE GROUP INC.
    Inventors: Yihong Yao, Jiaqi Huang, Shigui Zhu, Wei Zhu, Xin Yao, Zhiyuan Li, Li Zhang, Lin Zhu, Anyun Ma, Yutian Wei, Yanfeng Li, Qingxia Wang, Jiaping He
  • Patent number: 11608369
    Abstract: Provided are a chimeric antigen receptor targeting CD20 antigen and a preparation method thereof. The extracellular antigen binding domain of the chimeric antigen receptor includes an antibody heavy chain variable region shown in SEQ ID NO: 7 or 9 or 33 and an antibody light chain variable region shown in SEQ ID NO: 11 or 13 or 35, and is capable of killing tumor cells.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: March 21, 2023
    Assignee: Cellular Biomedicine Group, Inc.
    Inventors: Yihong Yao, Jiaqi Huang, Shigui Zhu, Wei Zhu, Xin Yao, Zhiyuan Li, Li Zhang, Lin Zhu, Anyun Ma, Yutian Wei, Yanfeng Li, Qingxia Wang, Jiaping He
  • Publication number: 20230058188
    Abstract: Disclosed is a transient-state THz spectrometer applied to cells and biological macromolecules, including a femtosecond laser amplifier. A femtosecond laser output by the femtosecond laser amplifier is divided into two beams of pump light and probe light after passing through a beam splitter of which a transmission-reflection ratio is 7:3, the pump light is focused to irradiate a gap between electrodes of a nonlinear photoconductive antenna and emit a terahertz wave after successively passing through a half wave plate, a silver-plated reflector and a first lens, the terahertz wave forms a terahertz wave collineation after successively passing through a second lens, a slab waveguide, a third lens and an ITO film, the terahertz wave collineation and the probe light form a probe light collineation of wavefront tilt which is perpendicularly incident on a ZnTe crystal and detected and recorded by using a CCD camera.
    Type: Application
    Filed: January 13, 2021
    Publication date: February 23, 2023
    Inventors: Wei SHI, Lei HOU, Cheng MA, Chengang DONG, Lei YANG, Jiaguang HAN, Yanfeng LI, Chunmei OUYANG, Jianqiang GU, Liguo ZHU, Zhaohui ZHAI, Lianghui DU, Yi ZOU
  • Publication number: 20230047799
    Abstract: Provided is a pixel structure. The pixel structure includes: a first electrode, a second electrode, and a liquid crystal layer that are disposed on one side of a substrate and successively stacked, wherein one of the first electrode and the second electrode is a pixel electrode and the other of the first electrode and the second electrode is a common electrode, and the second electrode includes a plurality of electrode branches sequentially arranged in a first direction, wherein each of the electrode branches includes a first end portion, a body portion, and a second end portion that are successively connected in a second direction, the body portion including at least one body segment.
    Type: Application
    Filed: October 28, 2022
    Publication date: February 16, 2023
    Inventors: Wei REN, Wei LI, Yanfeng LI, Haoyi XIN, Jing LI, Jingjing XU, Chenrong QIAO, Yanyong SONG, Xu QIAO, Rula SHA, Min ZHANG
  • Publication number: 20230053305
    Abstract: The present invention provides a BCMA-targeted chimeric antigen receptor (CAR) as well as a preparation method therefor and an application thereof. Specifically, the present invention provides the BCMA-targeted CAR, which comprises a BCMA-targeted scFv, a hinge region, a transmembrane region, and an intracellular signal structure domain. The present invention provides a nucleic acid molecule for coding the CAR and a corresponding expression vector as well as CAR-T cells and application thereof. The CAR of the present invention targets BCMA-positive cells, and can be used for treating BCMA-positive B-cell lymphoma, multiple myeloma and plasma cell leukemia.
    Type: Application
    Filed: September 23, 2022
    Publication date: February 16, 2023
    Inventors: Yutian WEI, Lin ZHU, Yanfeng LI, Yihong YAO, Xin YAO, Jiaqi HUANG, Li ZHANG, Shigui ZHU, Xiaoteng LV
  • Publication number: 20230029891
    Abstract: An array substrate, which is provided with a plurality of sub-pixel regions arranged in an array, the plurality of sub-pixel regions comprising a plurality of white sub-pixel regions and a plurality of primary-color sub-pixel regions. The array substrate comprises a first substrate, and a plurality of sub-pixels arranged on one side of the first substrate. The plurality of sub-pixels comprise a plurality of white sub-pixels and a plurality of primary-color sub-pixels. In the column direction, each white sub-pixel is adjacent to at least one primary-color sub-pixel. Each sub-pixel has a plurality of light-shielding patterns.
    Type: Application
    Filed: June 10, 2021
    Publication date: February 2, 2023
    Inventors: Xueqiang QIAN, Dongchuan CHEN, Yanfeng LI, Yu XING, Kaixuan WANG, Bingyang LIU
  • Publication number: 20220411694
    Abstract: The invention relates to a phosphor with garnet structure and a light-emitting device comprising the phosphor, wherein the phosphor includes the following components in percentage by weight: 38.47-45.19% of Y element, 9.49-22.09% of Al element, 2.06-24.31% of Ga element, 27.3-32.04% of O element, 0.43-1.46% of Ce element. In the phosphor particles, the shortest distance from the surface of one side of the particle to the surface of the opposite side through the centroid of the particle is defined as R, the longest distance is R1, and 5 ?m?R?40 ?m; any distance from the particle surface to the centroid is r, and 0<r<½R; and the space with the distance from the particle surface to the centroid direction being less than or equal to r is defined as rinner.
    Type: Application
    Filed: May 19, 2022
    Publication date: December 29, 2022
    Inventors: Ronghui LIU, Shaowei QIN, Yuanhong LIU, Yanfeng LI, Xiaoxia CHEN, Xiaole MA, Yuan XUE
  • Patent number: 11498973
    Abstract: The present invention provides a BCMA-targeted chimeric antigen receptor (CAR) as well as a preparation method therefor and an application thereof. Specifically, the present invention provides the BCMA-targeted CAR, which comprises a BCMA-targeted scFv, a hinge region, a transmembrane region, and an intracellular signal structure domain. The present invention provides a nucleic acid molecule for coding the CAR and a corresponding expression vector as well as CAR-T cells and application thereof. The CAR of the present invention targets BCMA-positive cells, and can be used for treating BCMA-positive B-cell lymphoma, multiple myeloma and plasma cell leukemia.
    Type: Grant
    Filed: September 16, 2021
    Date of Patent: November 15, 2022
    Assignee: CELLULAR BIOMEDICINE GROUP HK LIMITED
    Inventors: Yutian Wei, Lin Zhu, Yanfeng Li, Yihong Yao, Xin Yao, Jiaqi Huang, Li Zhang, Shigui Zhu, Xiaoteng Lv
  • Publication number: 20220340640
    Abstract: Provided are a chimeric antigen receptor targeting CD20 antigen and a preparation method thereof. The extracellular antigen binding domain of the chimeric antigen receptor includes an antibody heavy chain variable region shown in SEQ ID NO: 7 or 9 or 33 and an antibody light chain variable region shown in SEQ ID NO: 11 or 13 or 35, and is capable of killing tumor cells.
    Type: Application
    Filed: June 3, 2022
    Publication date: October 27, 2022
    Inventors: Yihong YAO, Jiaqi HUANG, Shigui ZHU, Wei ZHU, Xin YAO, Zhiyuan LI, Li ZHANG, Lin ZHU, Anyun MA, Yutian WEI, Yanfeng LI, Qingxia WANG, Jiaping HE
  • Patent number: 11472858
    Abstract: Provided are a chimeric antigen receptor targeting CD20 antigen and a preparation method thereof. The extracellular antigen binding domain of the chimeric antigen receptor includes an antibody heavy chain variable region shown in SEQ ID NO: 7 or 9 or 33 and an antibody light chain variable region shown in SEQ ID NO: 11 or 13 or 35, and is capable of killing tumor cells.
    Type: Grant
    Filed: June 21, 2021
    Date of Patent: October 18, 2022
    Assignee: CELLULAR BIOMEDICINE GROUP HK LIMITED
    Inventors: Yihong Yao, Jiaqi Huang, Shigui Zhu, Wei Zhu, Xin Yao, Zhiyuan Li, Li Zhang, Lin Zhu, Anyun Ma, Yutian Wei, Yanfeng Li, Qingxia Wang, Jiaping He
  • Publication number: 20220324940
    Abstract: Provided are a chimeric antigen receptor targeting CD20 antigen and a preparation method thereof. The extracellular antigen binding domain of the chimeric antigen receptor includes an antibody heavy chain variable region shown in SEQ ID NO: 7 or 9 or 33 and an antibody light chain variable region shown in SEQ ID NO: 11 or 13 or 35, and is capable of killing tumor cells.
    Type: Application
    Filed: April 19, 2022
    Publication date: October 13, 2022
    Inventors: Yihong YAO, Jiaqi HUANG, Shigui ZHU, Wei ZHU, Xin YAO, Zhiyuan LI, Li ZHANG, Lin ZHU, Anyun MA, Yutian WEI, Yanfeng LI, Qingxia WANG, Jiaping HE
  • Publication number: 20220320345
    Abstract: The embodiments of the present disclosure provide an array substrate and a method for manufacturing the same, and a display device. The array substrate includes a substrate, wherein the substrate has a display region and a peripheral region surrounding the display region, the display region has a plurality of pixels arranged in an array, and each of the plurality of pixels includes a light transmission region and a light shielding region, and a light shielding block covering at least a part of the light transmission region of at least one pixel close to the peripheral region of the plurality of pixels.
    Type: Application
    Filed: June 21, 2022
    Publication date: October 6, 2022
    Inventors: Yanqing CHEN, Jianyun XIE, Wei LI, Cheng LI, Pan GUO, Yanfeng LI, Weida QIN, Ning WANG
  • Publication number: 20220291538
    Abstract: An array substrate has a display area and a bezel area located on at least one side of the display area. The bezel area includes a bonding region. The array substrate includes a substrate, a plurality of signal lines, a plurality of conductive bumps, and an insulating layer. The signal lines are disposed on the substrate. The conductive blocks are disposed on a portion of the substrate located in the bonding region, and a conductive bump is connected to at least one signal line. The insulating layer covers the plurality of signal lines and is located between every two adjacent conductive bumps. The conductive bump includes a conductive metal layer. A distance from a surface of the conductive metal layer away from the substrate to the substrate is less than or equal to a distance from a surface of the insulating layer away from the substrate to the substrate.
    Type: Application
    Filed: April 14, 2021
    Publication date: September 15, 2022
    Applicants: ORDOS YUANSHENG OPTOELECTRONICS CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Yanyong SONG, Yanfeng LI, Haoyi XIN, Xu QIAO, Chenrong QIAO, Wei REN, Yu XING, Jingjing XU, Rula SHA, Guolei ZHI, Guangshuai WANG, Liwen XIN, Jingwei HOU
  • Publication number: 20220288123
    Abstract: The present invention provides a combined chimeric antigen receptor targeting CD19 and CD20 and application thereof. Specifically, the present invention provides a combined chimeric antigen receptor targeting CD19 and CD20, which comprises a scFv targeting CD19 and CD20, a hinge region, a transmembrane region, and an intracellular signaling domain. The present invention provides a nucleic acid molecule encoding the chimeric antigen receptor and a corresponding expression vector, a CAR-T cell, and applications thereof. The experimental results show that the chimeric antigen receptor provided by the present invention shows extremely high killing ability against tumor cells. The chimeric antigen receptor of the present invention targets CD19 and/or CD20 positive cells and can be used to treat CD19 and/or CD20 positive B-cell lymphoma, leukemia and other diseases.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 15, 2022
    Inventors: Yihong YAO, Yanfeng LI, Yutian WEI, Shigui ZHU, Xin YAO, Jiaqi HUANG
  • Patent number: 11439665
    Abstract: The present invention provides a combined chimeric antigen receptor targeting CD19 and CD20 and application thereof. Specifically, the present invention provides a combined chimeric antigen receptor targeting CD19 and CD20, which comprises a scFv targeting CD19 and CD20, a hinge region, a transmembrane region, and an intracellular signaling domain. The present invention provides a nucleic acid molecule encoding the chimeric antigen receptor and a corresponding expression vector, a CAR-T cell, and applications thereof. The experimental results show that the chimeric antigen receptor provided by the present invention shows extremely high killing ability against tumor cells. The chimeric antigen receptor of the present invention targets CD19 and/or CD20 positive cells and can be used to treat CD19 and/or CD20 positive B-cell lymphoma, leukemia and other diseases.
    Type: Grant
    Filed: September 15, 2021
    Date of Patent: September 13, 2022
    Assignee: CELLULAR BIOMEDICINE GROUP HK LIMITED
    Inventors: Yihong Yao, Yanfeng Li, Yutian Wei, Shigui Zhu, Xin Yao, Jiaqi Huang
  • Publication number: 20220281945
    Abstract: Provided are a chimeric antigen receptor targeting CD20 antigen and a preparation method thereof. The extracellular antigen binding domain of the chimeric antigen receptor includes an antibody heavy chain variable region shown in SEQ ID NO: 7 or 9 or 33 and an antibody light chain variable region shown in SEQ ID NO: 11 or 13 or 35, and is capable of killing tumor cells.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 8, 2022
    Inventors: Yihong YAO, Jiaqi HUANG, Shigui ZHU, Wei ZHU, Xin YAO, Zhiyuan LI, Li ZHANG, Lin ZHU, Anyun MA, Yutian WEI, Yanfeng LI, Qingxia WANG, Jiaping HE
  • Publication number: 20220279741
    Abstract: A decision-making method for variable rate irrigation management includes the following steps: S1: sampling a soil from a root zone of a crop in an area controlled by an irrigation sprinkler, and measuring compositions of separates of the sampled soil; S2: managing and dividing the area controlled by the irrigation sprinkler according to an AWC of the soil in the root zone of the crop; S3: constructing an optimized soil moisture sensor network; S4: placing ground-fixed canopy temperature sensors; S5: constructing an optimized airborne canopy temperature sensor network centered on the center pivot; and S6: performing a variable rate irrigation by using the optimized soil moisture sensor network, the fixed canopy temperature sensors, the optimized airborne canopy temperature sensor network and an automatic weather station. The method optimizes the placement and quantity of the soil moisture sensor network and the canopy temperature sensor network to improve the measurement accuracy.
    Type: Application
    Filed: June 10, 2021
    Publication date: September 8, 2022
    Applicant: China Institute of Water Resources and Hydropower Research
    Inventors: Weixia ZHAO, Jiusheng LI, Yanfeng LI, Zhen WANG, Jun WANG
  • Publication number: 20220249568
    Abstract: The present invention provides a combined chimeric antigen receptor targeting CD19 and CD20 and application thereof. Specifically, the present invention provides a combined chimeric antigen receptor targeting CD19 and CD20, which comprises a scFv targeting CD19 and CD20, a hinge region, a transmembrane region, and an intracellular signaling domain. The present invention provides a nucleic acid molecule encoding the chimeric antigen receptor and a corresponding expression vector, a CAR-T cell, and applications thereof. The experimental results show that the chimeric antigen receptor provided by the present invention shows extremely high killing ability against tumor cells. The chimeric antigen receptor of the present invention targets CD19 and/or CD20 positive cells and can be used to treat CD19 and/or CD20 positive B-cell lymphoma, leukemia and other diseases.
    Type: Application
    Filed: April 15, 2022
    Publication date: August 11, 2022
    Inventors: Yihong YAO, Yanfeng LI, Yutian WEI, Shigui ZHU, Xin YAO, Jiaqi HUANG
  • Patent number: 11404582
    Abstract: The embodiments of the present disclosure provide an array substrate and a method for manufacturing the same, and a display device. The array substrate includes a substrate, wherein the substrate has a display region and a peripheral region surrounding the display region, the display region has a plurality of pixels arranged in an array, and each of the plurality of pixels includes a light transmission region and a light shielding region, and a light shielding block covering at least a part of the light transmission region of at least one pixel close to the peripheral region of the plurality of pixels.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: August 2, 2022
    Assignees: ORDOS YUANSHENG OPTOELECTRONICS CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Yanqing Chen, Jianyun Xie, Wei Li, Cheng Li, Pan Guo, Yanfeng Li, Weida Qin, Ning Wang
  • Patent number: 11396454
    Abstract: A negative thermal expansion material and a preparation method thereof, and a negative thermal expansion film and a preparation method thereof are provided. The negative thermal expansion material includes Eu0.85Cu0.15MnO3-?, wherein 0???2.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: July 26, 2022
    Assignees: ORDOS YUANSHENG OPTOELECTRONICS CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Wei Li, Pan Guo, Yanqing Chen, Ning Wang, Weida Qin, Haoyi Xin, Yanfeng Li, Chao Li, Yongchao Wang